{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:32:17Z","timestamp":1777566737759,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004564","name":"Ministarstvo Prosvete, Nauke i Tehnolo\u0161kog Razvoja","doi-asserted-by":"publisher","award":["172006"],"award-info":[{"award-number":["172006"]}],"id":[{"id":"10.13039\/501100004564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018992","name":"Serbian Academy of Sciences and Arts","doi-asserted-by":"publisher","award":["01-2019-F65"],"award-info":[{"award-number":["01-2019-F65"]}],"id":[{"id":"10.13039\/501100018992","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejmech.2019.111712","type":"journal-article","created":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:29:31Z","timestamp":1568806171000},"page":"111712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Structure based design, synthesis and in\u00a0vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2\u2032 or C-3\u2032 positions"],"prefix":"10.1016","volume":"183","author":[{"given":"Vesna","family":"Koji\u0107","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0924-1041","authenticated-orcid":false,"given":"Mirjana","family":"Popsavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa\u0161a","family":"Spai\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitar","family":"Jakimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Kova\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milo\u0161","family":"Svir\u010dev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lidija","family":"Aleksi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bojana Sre\u0107o","family":"Zelenovi\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9910-2987","authenticated-orcid":false,"given":"Velimir","family":"Popsavin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111712_bib1","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3762\/bjoc.14.65","article-title":"Recent advances in synthetic approaches for medicinal chemistry of C-nucleosides","volume":"14","author":"Temburnikar","year":"2018","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib2","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1016\/j.bmcl.2017.07.073","article-title":"Pyrrolo[2,1-f][1,2,4]triazines: from C-nucleosides to kinases and back again, the remarkable journey of a versatile nitrogen heterocycle, Bioorg","volume":"27","author":"Ott","year":"2017","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib3","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1021\/acs.jmedchem.5b01157","article-title":"C-Nucleosides to be revisited","volume":"59","author":"De Clercq","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib4","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2174\/1568026614666140423095331","article-title":"Recent advances on the enantioselective synthesis of C-nucleosides inhibitors of inosine monophosphate dehydrogenase (IMPDH)","volume":"14","author":"Merino","year":"2014","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2174\/138527208786786318","article-title":"Synthesis and medicinal properties of 2-deoxyribose and ribose C-nucleosides","volume":"12","author":"Adamo","year":"2008","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib6","first-page":"80","article-title":"Tiazofurin ICN pharmaceuticals","volume":"1","author":"Grifantini","year":"2018","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.ejmech.2019.111712_bib7","first-page":"1657","article-title":"Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment","volume":"127","author":"Gandin","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2019.111712_bib8","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1021\/cr900021w","article-title":"IMP dehydrogenase: structure, mechanism, and inhibition","volume":"109","author":"Hedstrom","year":"2009","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111712_bib9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2174\/0929867043455648","article-title":"Cofactor mimics as selective inhibitors of NAD-dependent inosine monophospate dehydrogenase (IMPDH) - the major therapeutic target","volume":"11","author":"Pankiewicz","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0065-2571(03)00021-9","article-title":"Targeting signal transduction","volume":"43","author":"Weber","year":"2003","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.ejmech.2019.111712_bib11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.toxlet.2003.10.013","article-title":"Erythrocytotoxicity of tiazofurin in\u00a0vivo and in\u00a0vitro detected by scanning probe microscopy","volume":"146","author":"Vrani\u0107-Mandu\u0161i\u0107","year":"2004","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib12","first-page":"181","article-title":"Hematological toxicity associated with tiazofurin influence on erythropoiesis","volume":"14","author":"Vrani\u0107","year":"2000","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib13","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1016\/S0040-4039(01)81174-6","article-title":"Synthesis of 2-\u03b2-d-ara- and 2-\u03b2-d-xylofuranosylthiazole-4-carboxamide","volume":"25","author":"Mao","year":"1985","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib14","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/jm00400a024","article-title":"Ara-tiazofurin: conservation of structural features in an unusual thiazole nucleoside","volume":"31","author":"Goldstein","year":"1988","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib15","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0006-291X(05)81155-6","article-title":"Cytotoxicity of tiazofurin and its arabinose and xylose analogues in K562 cells","volume":"180","author":"Zhen","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2019.111712_bib16","doi-asserted-by":"crossref","first-page":"6700","DOI":"10.1016\/j.bmcl.2012.08.093","article-title":"Synthesis and in\u00a0vitro antitumor screening of 2-(\u03b2-d-xylofuranosyl)thiazole-4-carboxamide and two novel tiazofurin analogs with substituted tetrahydrofurodioxol moiety as a sugar mimic","volume":"22","author":"Popsavin","year":"2012","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111712_bib17","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/j.bmcl.2019.04.023","article-title":"Xylo-C-nucleosides with a pyrrolo[2,1-f][1,2,4]triazin-4-amine heterocyclic base: synthesis and antiproliferative properties, Bioorg","volume":"29","author":"Nie","year":"2019","journal-title":"Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib18","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejmech.2016.01.037","article-title":"Synthesis and in\u00a0vitro antitumour activity of tiazofurin analogues with nitrogen functionalities at the C-2\u2032 position","volume":"111","author":"Popsavin","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib19","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1073\/pnas.96.7.3531","volume":"96","author":"Colby","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111712_bib20","doi-asserted-by":"crossref","first-page":"5317","DOI":"10.1016\/j.bmcl.2006.07.086","article-title":"2-(3-Amino-3-deoxy-\u03b2-d-xylofuranosyl)thiazole-4-carboxamide: a new tiazofurin analogue with potent antitumour activity","volume":"16","author":"Popsavin","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111712_bib21","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1016\/S0960-894X(03)00712-1","article-title":"De novo synthesis of two new cytotoxic tiazofurin analogues with modified sugar moieties","volume":"13","author":"Popsavin","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111712_bib22","author":"DiscoveryStudioVisualizer","year":"2016"},{"key":"10.1016\/j.ejmech.2019.111712_bib23","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1016\/S0040-4039(02)01470-3","article-title":"A\u00a0concise route to tiazofurin","volume":"43","author":"Brown","year":"2002","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib24","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0040-4039(00)77147-4","article-title":"Reinvestigation of a modified Hantzsch thiazole synthesis","volume":"35","author":"Aguilar","year":"1994","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2019.111712_bib25","first-page":"4827","article-title":"Evaluation of a soluble tetrazolium\/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines","volume":"48","author":"Scudiero","year":"1988","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2019.111712_bib26","unstructured":"Antiproliferative Activities of Analogues 3 and 4 against Four Cell Lines Were Reported in the Preliminary Communications, but after 24-hours of cells treatment (see, references 20 and 21)."},{"key":"10.1016\/j.ejmech.2019.111712_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.ejmech.2017.03.088","article-title":"Synthesis and in\u00a0vitro antitumour activity of crassalactone D, its stereoisomers and novel cinnamic ester derivatives","volume":"134","author":"Kova\u010devi\u0107","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111712_bib28","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/onc.2010.429","article-title":"PI3K inhibitors prime neuroblastoma cells for chemotherapy by shifting the balance towards pro-apoptotic Bcl-2 proteins and enhanced mitochondrial apoptosis","volume":"30","author":"Bender","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.111712_bib29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/(SICI)1098-2280(1999)33:2<167::AID-EM9>3.0.CO;2-D","article-title":"Detection of crosslinks with the Comet assay in relationship to genotoxicity and cytotoxicity","volume":"33","author":"Merk","year":"1999","journal-title":"Environ. Mol. Mutagen."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419308645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:04:22Z","timestamp":1759327462000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419308645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":29,"alternative-id":["S0223523419308645"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111712","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure based design, synthesis and in\u00a0vitro antitumour activity of tiazofurin stereoisomers with nitrogen functions at the C-2\u2032 or C-3\u2032 positions","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111712","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111712"}}